We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $446M
1-Year Est. Return 13.33%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
+13.33%
3 Year Est. Return
+41.32%
5 Year Est. Return
+5.19%
10 Year Est. Return
+180.06%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 46.15%
2 Miscellaneous 21.2%
3 Communication Services 10.02%
4 Financials 7.66%
5 Consumer Discretionary 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMUS icon
151
T-Mobile US
TMUS
$189B
$814K 0.05%
13,000
-14,000
-52% -$940K
VRTX icon
152
Vertex Pharmaceuticals
VRTX
$130B
$812K 0.05%
5,000
LITS
153
Lite Strategy Inc
LITS
$34.7M
$801K 0.05%
+19,826
New +$1.22M
MCD icon
154
McDonald's
MCD
$176B
$799K 0.05%
4,550
+1,500
+49% +$266K
PLX icon
155
Protalix BioTherapeutics
PLX
$216M
$795K 0.05%
263,140
LIN icon
156
Linde
LIN
$213B
$794K 0.05%
+5,174
New +$818K
EXPD icon
157
Expeditors International
EXPD
$24.6B
$791K 0.05%
+11,800
New +$829K
GE icon
158
GE Aerospace
GE
$325B
$785K 0.05%
22,536
+4,800
+27% +$217K
SCHW
159
Charles Schwab
SCHW
$182B
$780K 0.05%
19,000
RYTM icon
160
Rhythm Pharmaceuticals
RYTM
$6.75B
$779K 0.05%
+29,720
New +$821K
SYRE icon
161
Spyre Therapeutics
SYRE
$8.04B
$778K 0.05%
+3,886
New +$824K
AIZ icon
162
Assurant
AIZ
$14B
$765K 0.05%
8,700
APA icon
163
APA Corp
APA
$15.7B
$749K 0.04%
28,000
+3,000
+12% +$111K
NEM icon
164
Newmont
NEM
$128B
$742K 0.04%
21,200
+12,000
+130% +$389K
ASMB icon
165
Assembly Biosciences
ASMB
$519M
$737K 0.04%
+2,833
New +$820K
UAA icon
166
Under Armour
UAA
$2.15B
$716K 0.04%
+40,000
New +$821K
IFF icon
167
International Flavors & Fragrances
IFF
$21.5B
$715K 0.04%
5,400
+1,500
+38% +$208K
TLPH icon
168
Talphera
TLPH
$61.8M
$709K 0.04%
15,085
-8,867
-37% -$594K
QCOM icon
169
Qualcomm
QCOM
$197B
$690K 0.04%
12,300
CTAS icon
170
Cintas
CTAS
$79.8B
$686K 0.04%
16,400
A icon
171
Agilent Technologies
A
$43.3B
$675K 0.04%
10,160
IBM icon
172
IBM
IBM
$224B
$673K 0.04%
6,187
+539
+10% +$64.7K
TEVA icon
173
Teva Pharmaceutical Industries Limited
TEVA
$44.9B
$666K 0.04%
43,000
CDTX
174
DELISTED
Cidara Therapeutics
CDTX
$659K 0.04%
15,334
ORCL icon
175
Oracle
ORCL
$433B
$659K 0.04%
14,655
-24,000
-62% -$1.15M

Similar funds

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.